Patents
Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
10/2005
10/12/2005CN1681768A Process for production of high-purity enamines
10/06/2005US20050222121 Atypical antipsychotic agents having low affinity for the D2 receptor
10/05/2005CN1678597A Novel quaternary ammonium compounds
09/2005
09/28/2005EP1578198A1 Pesticidal dibenzo(hetero)azepine derivatives
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/15/2005DE102004010830A1 Neue 1,4-Benzooxazepane oder 1,4-Benzothiazepane und Derivate New 1.4-Benzooxazepane or 1,4-Benzothiazepane and derivatives
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/09/2005WO2005082873A2 1,4-benzothiazepans and derivatives thereof
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/01/2005WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
08/2005
08/31/2005EP1567524A1 Thia-epothilone derivatives for the treatment of cancer
08/24/2005EP1565448A2 METHOD OF PREPARING 10H-DIBENZO b,f 1,4 THIAZEPIN-11-ONE
08/03/2005CN1213036C Novel amide derivatives
07/2005
07/26/2005US6921760 Psychotherapeutic agents.
07/21/2005WO2005066146A1 Method for the production of a thiazolo[3,4,5-de][4,1]benzothiazepine-type product
07/21/2005WO2004047722A8 METHOD OF PREPARING 10H-DIBENZO[b,f][1,4]THIAZEPIN-11-ONE
07/20/2005EP1554250A1 Novel lactams and uses thereof
07/13/2005EP1553077A1 Process for production of high-purity enamines
07/13/2005CN1639140A Benzothiazepine derivatives for the treatment of hyperlipidemia
06/2005
06/30/2005US20050143576 Process for production of high-purity enamines
06/30/2005CA2549072A1 Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/14/2005US6906058 Prevent bile acid transportation; anticholesterol agents
06/02/2005WO2005049585A1 Macrocyclic lactams and pharmaceutical use thereof
06/02/2005CA2544751A1 Macrocyclic lactams and pharmaceutical use thereof
06/01/2005EP1535913A1 Novel quaternary ammonium compounds
05/2005
05/25/2005EP1532115A2 Protease inhibitors
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/10/2005US6890919 Atypical antipsychotic agents having low affinity for the D2 receptor
05/10/2005CA2001515C Process for preparing optically active glycidate esters
05/06/2005WO2005014590A3 Procedure for preparing 11-(4`2-(2-hydroxyethoxy )ethyl!-1-piperazinyl!-dibenzo`b,f!`1,4!thiazepine
04/2005
04/19/2005US6881839 Process for preparing diltiazem using a heterogeneous trifunctional catalyst
04/14/2005US20050080265 Sleep disorders; side effect reduction
04/06/2005CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases
03/2005
03/31/2005WO2005028459A1 Preparation method for quetiapine
03/31/2005WO2005028458A1 Preparation of quetiapine
03/31/2005WO2005028457A1 Preparation of quetiapine
03/31/2005CA2538866A1 Preparation of quetiapine
03/31/2005CA2538745A1 Preparation of quetiapine
03/30/2005EP1326616B1 Use of quetiapine for attention deficit hyperactivity disorder or conduct disorder
03/30/2005EP1115881B1 Process for the enzymatic kinetic resolution of 3-phenylglycidates by transesterification with aminoalcohols
03/23/2005CN1599731A Benzothiazepine derivatives
03/17/2005WO2004073642A3 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands
03/17/2005US20050059699 N-acylated lipophilic amino acid derivatives
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/01/2005US6861419 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof
02/2005
02/17/2005WO2005014590A2 Procedure for preparing 11-(4`2-(2-hydroxyethoxy )ethyl!-1-piperazinyl!-dibenzo`b,f!`1,4!thiazepine
02/17/2005WO2004080391A3 Novel antibacterial agents
02/17/2005US20050038009 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)- alpha -[N-((S)-1-carboxypropyl) carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine
02/16/2005CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia
02/10/2005WO2005012274A1 Process for the preparation of 11-(1-piperazinyl)dibenzo `b, f! `1 ,4!-thiazepine, an intermediate in the synthesis of the antipsychotic drug quetiapine
02/10/2005US20050032776 Benzothiazepine derivatives for the treatment of hyperlipidemia
02/09/2005CN1188404C Cyclic compound
01/2005
01/27/2005US20050020571 Antiserotonine agents; psycholgical disorders; headaches
01/13/2005US20050009805 Quaternary ammonium 1,4-benzothiazepinedione derivatives useful for treatment and prevention of hyperlipidemia, cholestasis-accompanying hepatopathy, particularly primary biliary cirrhosis and primary sclerosing cholangitis, and obesity and fatty liver.
01/13/2005US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis
01/12/2005EP1495008A1 Synthesis of quetiapine and pharmaceutically acceptable salts thereof
01/12/2005EP1165532B1 Antibacterial agents
12/2004
12/23/2004WO2004078735A9 Novel polymorphs of quetiapine fumarate
12/16/2004US20040254160 Benzothiazepine derivatives
12/08/2004EP1482945A1 Crystalline forms of quetiapine hemifumarate
12/02/2004WO2004047722A3 METHOD OF PREPARING 10H-DIBENZO[b,f][1,4]THIAZEPIN-11-ONE
12/02/2004US20040242562 stable, reproducible two crystalline forms; prepared by dissolving quetiapine free base and fumaric acid in suitable solvent and crystallizing fumarate salt; suitable solvents are ketones like acetone, methyl iso butyl ketone; esters like ethyl acetate, ethyl formate, methyl acetate; and mixture
12/01/2004CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004CN1177839C Process for preparation of quetiapine and intermediates therefor
11/2004
11/24/2004EP1263747B1 1,5-benzothiazepines and their use as hypolipidaemics
11/10/2004EP1117408B9 Use of diltiazem for treating retinal pathologies
11/04/2004US20040220400 Using phase transfer catalyst and base in solvent; refluxing
10/2004
10/26/2004US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors
10/20/2004CN1537847A Internediate for preparing quetiapin and preparation method of the intermediate
10/14/2004US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction
10/07/2004US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine
09/2004
09/23/2004WO2004080391A2 Novel antibacterial agents
09/23/2004US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits
09/23/2004US20040186093 Cyclizing a sulfamide acyclic compound with a deprotonating agent in an aprotic solvent; forming an intermediates for the preparation of naphthyridine carboxamide compounds which are HIV integrase enzyme inhibitors; commercial available starting materials alkanesulfonyl halides, haloalkylamine
09/23/2004CA2801100A1 Novel antibacterial agents
09/16/2004WO2004078735A1 Novel polymorphs of quetiapine fumarate
09/16/2004WO2003104257A3 Protease inhibitors
09/10/2004WO2004076431A1 Synthesis of quetiapine and pharmaceutically acceptable salts thereof
09/10/2004WO2004076430A1 Benzothiazepine and benzothiepine derivatives
09/10/2004CA2516646A1 Synthesis of quetiapine and pharmaceutically acceptable salts thereof
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/02/2004WO2004073642A2 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands
09/02/2004CA2515706A1 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands
08/2004
08/03/2004US6770668 Pharmaceutically active compounds and methods of use
07/2004
07/27/2004CA2124136C Method for producing benzylidene derivatives
07/15/2004WO2004058734A1 Process for preparing diltiazem using a heterogeneous trifunctional catalyst
07/14/2004EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications
07/14/2004EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
07/14/2004CN1157387C Process for preparing 11-amino-3-chlorine-6, 11-dihydrogen-5, 5-dioxo-6-methyl-dibenzo [c,f][1,2] thiazine and application of synthetic tianeptine
07/08/2004WO2004056182A1 Pesticidal dibenzo(hetero)azepine derivatives
07/01/2004US20040127704 Process for preparing diltiazem using a heterogeneous trifunctional catalyst
06/2004
06/23/2004EP1430040A1 Benzothiazepine derivatives
06/16/2004EP1427713A1 Benzothiazepine derivatives for the treatment of hyperlipidemia
06/16/2004EP1427423A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
06/16/2004EP1117408B1 Use of diltiazem for treating retinal pathologies
06/15/2004US6750255 Calcium receptor-active compounds
06/10/2004WO2004047722A2 METHOD OF PREPARING 10H-DIBENZO[b,f][1,4]THIAZEPIN-11-ONE
06/02/2004EP1423112A1 A combination of quetiapine and zolmitriptan
05/2004
05/12/2004EP1417162A1 Chromatographic separation of enantiomers of protected amino acids via smb-method
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 20